Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 369 | 305 | 237 | 0 |
| Operating Income | -369 | -305 | -237 | N/A |
| Other Income | 2,099 | -994 | 3,055 | 0 |
| Pre-tax Income | 1,730 | -1,299 | 2,818 | 0 |
| Net Income Continuous | 1,730 | -1,299 | 2,818 | N/A |
| Net Income | $1,730 | $-1,299 | $2,818 | $N/A |
| EPS Basic Total Ops | 0.10 | -0.07 | 0.16 | N/A |
| EPS Basic Continuous Ops | 0.50 | -0.38 | 0.82 | N/A |
| EPS Diluted Total Ops | 0.10 | -0.07 | 0.16 | N/A |
| EPS Diluted Continuous Ops | 0.50 | -0.38 | 0.82 | N/A |
| EBITDA(a) | $-369 | $-305 | $-237 | $N/A |